Abbott
Ian Buggs holds an MBA/MPIA and currently serves as the Global Finance Director for R&D and Marketing in Heart Failure at Abbott since March 2024. Prior experience includes a role as Finance Director for Middle East & Africa at Mundipharma, and Head of Finance for Gulf at Amgen, where responsibilities included business planning and financial analysis. Ian Buggs has been a Board Member of the University of Pittsburgh Business Alumni Association, contributing to the support of academic and professional development. Previous positions also include Finance Director for Consumer Health Middle East at Pfizer, where significant integration activities took place during a joint venture with GSK. Ian Buggs possesses a strong educational background with degrees from Carnegie Mellon University and the University of Pittsburgh, complemented by experience in financial reporting and corporate compliance.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Abbott
381 followers
Abbott is a healthcare company that develops products to improve quality of life at all stages. Abbott’s portfolio includes diagnostics, medical devices, nutritionals and branded generic medicines. They have over 110,000 employees globally with customers in over 160 countries worldwide. With 130 years of history, Abbott is an established presence in the healthcare industry. Abbott’s portfolio has products targeted towards several categories, including cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines. Some of Abbott’s best known brands include: Similac, a line of infant formulas; EleCare, a nutritionally complete, amino acid-based medical good and infant formula with iron; PediaSure, balanced nutrition for kids on the go; Pedialyte, a formulation to prevent dehydration by restoring lost minerals and nutrients; Ensure, a line of nutrition products supporting active lifestyles; FreeStyle, a glucose monitor to make managing diabetes easier and more convenient; FreeStyle Libre, a handheld reader with a small sensor that continuously monitors glucose levels, eliminating routine finger sticks; and Glucerna, specialized nutrition to help maintain health blood glucose levels and manage diabetes.